作者: Sheng-Yung Chang , John Martin
DOI:
关键词: Alpha interferon 、 Immunology 、 Virology 、 Hepatitis C virus 、 Medicine
摘要: The present invention relates to the identification of prognostic markers useful in determining response hepatitis c virus (HCV) infected patients interferon alpha (IFN-α) treatment. studies provide biomarkers that can be used discern sustained responders and non-responders IFN-α This information should enable treating physicians help make more informed decisions.